Skip to main content
Equibles

SUVRETTA CAPITAL MANAGEMENT, LLC

Position in IFRX — InflaRx N.V.

CIK 1569064 New York, NY
Back to IFRX Full portfolio

Position in IFRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$51,371,958
+$44,279,043 QoQ
Shares Held
22,933,910
+189.1% QoQ
Ownership
15.6%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#1
of 62 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IFRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,923,514,073 across 34 Biotechnology names. IFRX ranks #16 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MANE
Veradermics, Inc
 4,168,970 $512,533,171
2 ARQT
Arcutis Biotherapeutics, Inc.
 12,437,000 $326,098,140
3 LEGN
Legend Biotech Corp
 7,070,000 $204,181,600
4 PVLA
Palvella Therapeutics, Inc.
 1,135,406 $173,512,744
5 AVBP
ArriVent BioPharma, Inc.
 4,515,531 $156,869,546
6 BNTC
Benitec Biopharma Inc.
 11,548,351 $154,516,936
7 BHVN
Biohaven Ltd.
 10,286,937 $153,069,622
8 RCUS
Arcus Biosciences, Inc.
 4,776,423 $147,257,121

All Filings in IFRX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,371,958 22,933,910
2026-03-31 $7,092,915 7,933,910
2025-12-31 $8,013,249 7,933,910
2025-09-30 $8,688,439 6,483,910
2025-06-30 $5,122,288 6,483,910
2025-03-31 $6,613,588 6,483,910
2024-12-31 $14,162,757 5,733,910
2024-09-30 $8,772,882 5,733,910
2024-06-30 $9,977,003 5,733,910
2024-03-31 $8,830,221 5,733,910
2023-12-31 $9,346,273 5,733,910
2023-09-30 $17,087,051 5,733,910
2023-06-30 $25,573,238 5,733,910
2023-03-31 $4,163,705 2,146,240
2022-12-31 $6,653,344 2,146,240
2022-09-30 $5,666,073 2,146,240
2022-06-30 $4,763,250 3,285,000
2022-03-31 $6,011,550 3,285,000
2021-12-31 $15,636,600 3,285,000
2021-09-30 $8,508,150 3,285,000
2021-06-30 $9,756,450 3,285,000
2021-03-31 $12,811,500 3,285,000